Three months after Bristol Myers Squibb revealed the success of two phase 3 trials of its oral targeted therapy Sotyktu in ...

Late-stage data also showed that Johnson & Johnson’s icotrokinra was superior to Bristol Myers Squibb’s Sotyktu at clearing ...

J&J's head of immunodermatology Liza O'Dowd said that the "robust results" with its oral IL-23 drug have the potential to ...

Johnson & Johnson’s once-daily oral peptide has bested Bristol Myers Squibb’s reigning oral psoriasis med Sotyktu in a ...

Two-thirds of patients with moderate or severe plaque psoriasis had complete or nearly complete clearance at 4 months with an ...

The following is a summary of “Effect of spesolimab on sustained disease control in patients with generalized pustular ...

US pharma major Bristol Myers Squibb has announced positive data from the pivotal Phase III POETYK PsA-2 trial evaluating the ...

Standout combination of complete skin clearance and favorable safety profile in a once daily pill could shift treatment paradigm Nearly half of patients with moderate-to-severe ...

Protagonist Therapeutics broke out Monday after the company's drug topped its rival from Bristol in a psoriasis study.

Board-certified dermatologist Dr. Deanne Mraz, recommends this Aveeno bar soap for anyone looking for an ultra-gentle and ...

Coconut water is an excellent solution to keep skin hydrated. It is rich in electrolytes that can penetrate the skin and provides skin with much-needed moisture when dehydrated, like after exercise.

Experts stressed the importance of dermatologists engaging in climate advocacy and adopting sustainable practices, as their ...